Persistent Benefit of Two-Year Artemisia annua Sublingual Immunotherapy for Seasonal Allergic Rhinoconjunctivitis
A 2-year course of SLIT with A. annua allergen extract significantly alleviated symptoms and reduced medication use in SARC patients, with clinical benefits persisting for at least 1-year post-treatment phase.
Authors
- Xueyan Wang (ORCID: https://orcid.org/0000-0001-9973-540X)
- Jingyi Liu (ORCID: https://orcid.org/0000-0002-8079-655X)
- Yang Liu (ORCID: https://orcid.org/0000-0003-0320-9574)
- Tingting Ma (ORCID: https://orcid.org/0000-0002-8488-651X)
- Yuting Wu (ORCID: https://orcid.org/0009-0007-1510-6464)
- Tianfei Lan
- Kaili Zheng
Institutions
- Capital Medical University (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1159/000548444
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00